ArticleFrontiers in immunology2025

Sintilimab for the treatment of lung adenocarcinoma-induced immune-related hypophysitis: a case report.

Ming-Xing Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.